首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Lipid metabolism reprogramming in colorectal cancer
Authors:Dan Chen  Xuebing Zhou  PengYu Yan  Chunyu Yang  Yuan Li  Longzhe Han  Xiangshan Ren
Institution:1. Department of Pathology & Cancer Research Center, Yanbian University Medical College, Yanji, China

Key Laboratory of Pathobiology, Yanbian University, State Ethnic Affairs Commission, Yanji, China;2. Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China;3. Key Laboratory of Pathobiology, Yanbian University, State Ethnic Affairs Commission, Yanji, China;4. Department of Pathology & Cancer Research Center, Yanbian University Medical College, Yanji, China

Abstract:The hallmark feature of metabolic reprogramming is now considered to be widespread in many malignancies, including colorectal cancer (CRC). Of the gastrointestinal tumors, CRC is one of the most common with a high metastasis rate and long insidious period. The incidence and mortality of CRC has increased in recent years. Metabolic reprogramming also has a significant role in the development and progression of CRC, especially lipid metabolic reprogramming. Many studies have reported that lipid metabolism reprogramming is similar to the Warburg effect with typical features affecting tumor biology including proliferation, migration, local invasion, apoptosis, and other biological behaviors of cancer cells. Therefore, studying the role of lipid metabolism in the occurrence and development of CRC will increase our understanding of its pathogenesis, invasion, metastasis, and other processes and provide new directions for the treatment of CRC. In this paper, we mainly describe the molecular mechanism of lipid metabolism reprogramming and its important role in the occurrence and development of CRC. In addition, to provide reference for subsequent research and clinical diagnosis and treatment we also review the treatments of CRC that target lipid metabolism.
Keywords:colorectal cancer  lipid metabolism reprogramming  metastasis  proliferation  targeted drugs
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号